Pentosan Polysulfate， 一种新药用来治疗骨性关节炎 （ZT）

ISSN: 2167-7921

Journal of Arthritis

 

• Home
• Editorial Panel
• Instructions for Authors
• Submit Manuscript
• Articles in press
• Current Issue
• Past Issues
• Special Issues
• Metrics
• Contact

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on 
Medical, Pharma, Engineering, Science, Technology and Business

CommentaryOpen Access

Pentosan Polysulfate as a Disease Modifier of Cartilage Degeneration in Experimental Osteoarthritis

Ahmed M Elmesiry1*, Magdi A Seleim2, Ali A Mansour3 and David Cullis-Hill4

1Diagnostic Imaging and Endoscopy, Animal Reproduction Research Institute, Agriculture Research Center, 12556 Haram, Giza, Egypt

2Department of Surgery, Kafrelsheikh University, 33156 Kafrelsheikh, Egypt

3Department of Anatomy, Kafrelsheikh University, 33156 Kafrelsheikh, Egypt

4Sylvan Scientific Pty Ltd, 111 Bronte Rd, Bondi Junction, Sydney, NSW 2022, Australia

*Corresponding Author:

Ahmed M Elmesiry
Researcher, Animal Reproduction Research Institute Diagnostic Imaging and Endoscopy
5 El-Aharam Garden st, Al- Haram, Giza 12556, Egypt
Tel: [phone]
E-mail: [e-mail]

Received date: May 03, 2016; Accepted date: May 20, 2016; Published date: May 31, 2016

Citation: Elmesiry AM, Seleim MA, Mansour AA, Hill DC (2016) Pentosan Polysulfate as a Disease Modifier of Cartilage Degeneration in Experimental Osteoarthritis. J Arthritis 5:199. doi:10.4172/2167-7921.1000199

Copyright: © 2016 Elmesiry AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Arthritis

 View PDF Download PDF

Abstract

 

Reasons for performing study: Disease modifying drugs for Osteoarthritis (OA) is an important trend of development of an appropriate therapeutic protocol for both human and animal. To date no ideal OA treatment protocol has been described. Objectives: To assess clinical, histologic, and biochemical effects of sodium pentosan polysulfate (NaPPS) administered intramuscullary (IM) for treatment of experimentally induced osteoarthritis in donkeys. Study design: OA was induced using repeated injection of allogenous donkey cartilage. Six donkeys received NaPPS (3 mg/kg, IM) on study days 70, 77, 84, and 91. Six control donkeys received the same volume of saline (0.9% w/v NaCl) IM on study days 70, 77, 84, and 91. Clinical, gross, histologic, histochemical, and biochemical findings as well as synovial fluid analysis were evaluated. Methods of testing hypotheses: Lameness score, carpal circumference, joint flexion angle, Synovial fluid analysis, light and scanning electron microscopy were evaluated. Results: Induction of osteoarthritis caused increase in the lameness score, joint circumference,synovial fluid calcium, phosphorus, magnesium, total protein and leukocyte count and cartilage damage. NaPPS treatment significantly reduced synovial fluid Ca, Mg, P and cartilage damage. Conclusions: NaPPS resulted in significant improvement in clinical signs and articular cartilage healing, and no adverse effects were detected confirming that NaPPS has disease-modifying properties. Potential relevance: NaPPS is a suitable therapeutic option for osteoarthritis in equines.

 

 

Post your comment